The Medical Letter on Drugs and Therapeutics
FROM
ISSUE 1599
ISSUE 1599
June 1, 2020
Issue 1599
Subscribers: Log in to read full issue. Not a subscriber? Subscribe or purchase issue.
In Brief: Respiratory Depression with Gabapentinoids
June 1, 2020 (Issue: 1599)
The FDA has required new warnings in the labels of
gabapentin (Neurontin, and others) and pregabalin (Lyrica,
Lyrica CR, and generics) about the risk of life-threatening or
fatal respiratory depression in patients with respiratory risk
factors....more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.